T1	Disease 72 133	colorectal cancer (CRC) with microsatellite instability (MSI)
#1	AnnotatorNotes T1	not found
T10	Disease 466 469	CRC
T11	Biomarker 481 486	MSI-H
T12	Biomarker 608 691	low expression of DNA repair genes (MLH1, MLH3, PMS1, PMS2, ATR, PRKDC, ATM, BRCA2)
T13	Gene-Protein 656 660	PMS1
T14	Biomarker 708 713	MSI-H
T17	Biomarker 715 720	MSI-H
T18	Disease 810 822	MSI-H tumors
#8	AnnotatorNotes T18	not found
T20	Biomarker 839 877	diminished intra-tumoral heterogeneity
T21	Biomarker 889 964	higher expression of checkpoint molecules PD-1, PD-L1, CTLA4, LAG3 and TIM3
T22	Biomarker 1017 1039	low ATM, PMS2 and MLH3
T23	Disease 1053 1056	CRC
T24	Biomarker 1065 1105	decreased expression of DNA repair genes
T25	Biomarker 1129 1134	MSI-H
T26	Biomarker 1181 1191	higher TIL
T27	Biomarker 1196 1222	M1 macrophage infiltration
T29	Biomarker 1296 1337	expression of immune checkpoint molecules
T4	Biomarker 135 174	somatic mutations accumulate within DNA
T5	Disease 212 217	tumor
#14	AnnotatorNotes T5	DOID:162
T31	Biomarker 39 68	loss of DNA repair mechanisms
R2	Association Arg1:T31 Arg2:T1	
R1	Association Arg1:T4 Arg2:T1	
T2	Biomarker 343 373	increased tumor immunogenicity
T3	Biomarker 286 294	MSI-High
#2	AnnotatorNotes T3	not found
T6	Biomarker 296 301	MSI-H
#3	AnnotatorNotes T6	not found
#4	AnnotatorNotes T10	DOID:9256
T7	Gene-Protein 644 648	MLH1
#5	AnnotatorNotes T7	HGNC:7127
T8	Gene-Protein 650 654	MLH3
#7	AnnotatorNotes T8	HGNC:7128
#10	AnnotatorNotes T13	HGNC:9121
T9	Gene-Protein 662 666	PMS2
#11	AnnotatorNotes T9	HGNC:9122
T30	Gene-Protein 668 671	ATR
#15	AnnotatorNotes T30	HGNC:882
T32	Gene-Protein 685 690	BRCA2
#16	AnnotatorNotes T32	HGNC:1101
T33	Gene-Protein 680 683	ATM
#17	AnnotatorNotes T33	HGNC:795
T34	Gene-Protein 673 678	PRKDC
#18	AnnotatorNotes T34	HGNC:9413
T16	Biomarker 781 795	M1 macrophages
T19	Gene-Protein 931 935	PD-1
#6	AnnotatorNotes T19	HGNC:8760
T35	Gene-Protein 937 942	PD-L1
#9	AnnotatorNotes T35	HGNC:17635
T36	Gene-Protein 944 949	CTLA4
#19	AnnotatorNotes T36	 HGNC:2505
T37	Gene-Protein 951 955	LAG3
#20	AnnotatorNotes T37	HGNC:6476
T38	Gene-Protein 960 964	TIM3
#21	AnnotatorNotes T38	HGNC:18437
T39	Collection 839 964	diminished intra-tumoral heterogeneity as well as higher expression of checkpoint molecules PD-1, PD-L1, CTLA4, LAG3 and TIM3
R5	Prognostic-Good Arg1:T22 Arg2:T18	
T40	Gene-Protein 1021 1024	ATM
T41	Gene-Protein 1026 1030	PMS2
T42	Gene-Protein 1035 1039	MLH3
R6	Association Arg1:T39 Arg2:T18	
T43	Biomarker 1122 1127	MSI-H
T28	Biomarker 1234 1267	lower intra-tumoral heterogeneity
T45	Biomarker 1269 1274	MSI-H
T46	Biomarker 491 512	microsatellite stable
T47	Biomarker 514 517	MSS
T48	Collection 286 373	MSI-High (MSI-H) patients have favorable survival due to increased tumor immunogenicity
R4	Prognostic-Good Arg1:T25 Arg2:T23	
